Alliance Reg Med.png
The Alliance for Regenerative Medicine Releases 2018 Annual Data Report, Highlighting Sector Trends and Metrics
28 févr. 2019 11h04 HE | Alliance for Regenerative Medicine
WASHINGTON, D.C., Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today announced the release of its 2018 Annual Data Report, offering an in-depth...
hemostemix-logo-small.jpg
Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial
25 févr. 2019 08h30 HE | Hemostemix Inc.
CALGARY, Alberta, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from UC...
Uptick Newswire Hosts SANUWAVE Health, Inc. on the Stock Day Podcast to Discuss their DermaPACE Placement Strategy
25 févr. 2019 07h30 HE | SANUWAVE Health, Inc.
PHOENIX, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed SANUWAVE Health, Inc. (SNWV) (“the Company), a shock wave technology company initially focused on the...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Appoints New Board Member
20 févr. 2019 08h05 HE | Organovo, Inc.
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
PRED logo.jpg
Predictive Technology Group Reports Second Quarter Fiscal 2019 Financial
15 févr. 2019 08h00 HE | Predictive Technology Group, Inc.
SALT LAKE CITY, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Releases Agenda for 2019 Cell & Gene Meeting on the Mediterranean
13 févr. 2019 10h03 HE | Alliance for Regenerative Medicine
WASHINGTON, D.C, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results
07 févr. 2019 16h05 HE | Organovo, Inc.
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019Submit first IND in calendar 2020 SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc....
hemostemix-logo-small.jpg
Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA
04 févr. 2019 08h30 HE | Hemostemix Inc.
CALGARY, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) a biotechnology company focused on developing and commercializing...
Organogenesis_Logo_Corporate.jpg
Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz
24 janv. 2019 10h00 HE | Organogenesis Holdings Inc.
CANTON, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
New Medical Breakthroughs from International Scientists and Doctors in Stem Cells and Regenerative Medicine Miami, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) -- There is only one place in the world to interview and learn from all of the critical decision-makers from every stakeholder in the exploding field of...